Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty Drugsblue cross blue shield - louisiana prior auth list…
    Ask Trek AI about this page
    Currentblue cross blue shield - louisianaPolicy N/A

    Prescription Drugs Requiring Prior Authorization

    Customize your policy alerts

    Sign up for all blue cross blue shield - louisiana policy alerts

    Know when blue cross blue shield - louisiana releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This document lists prescription drugs that require prior authorization under the payer's pharmacy benefit; it governs clinicians and pharmacists submitting prior authorization requests processed by Express Scripts, Inc. (ESI).

    Policy Summary
    Payerblue cross blue shield - louisiana
    PolicyPrescription Drugs Requiring Prior Authorization
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Last ReviewFeb 26, 2023
    Next Review DateN/A
    Key ActionPhysicians must call Express Scripts, Inc. (ESI) at 1-800-842-2015 to obtain prior authorization.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    100+drugs listed requiring prior authorization (partial document)
    ESIprior auth processor
    Physician callmethod to obtain authorization
    >90/moquantity-limit note
    Revised 02/26document revision note

    Drugs Requiring Prior Authorization

    Prior authorization coverage criteria

    Drugs listed in these chunks require prior authorization to be covered by the plan.

    Prior authorization required: Coverage is provided only if prior authorization is obtained for the specific drug listed.

    Applies to drugs named in chunks 18-37

    The drugs listed in the cited segment require prior authorization to be covered under the plan. Coverage is provided only when the prescriber obtains approval from the pharmacy benefit manager before dispensing the medication, per the policy's prior authorization requirement.

    There are no explicit exclusions identified within these document segments. The lists enumerate products subject to administrative prior authorization but do not specify exclusion conditions for coverage in the cited chunks.

    The provided segment does not include any statements declaring medications or uses as not medically necessary. The content in this excerpt is limited to listing products that require prior authorization.

    There are no not medically necessary determinations present in the cited fragment. The text focuses on listing drug names and classifications that are subject to prior authorization under the pharmacy benefit.

    Listed Drugs and Coding Notes

    Listed drugs (brand and generic)NDC|mixed
    DOJOLVIGeneric Name = triheptanoin
    DOLOBIDGeneric Name = diflunisal
    DOPTELETGeneric Name = avatrombopag maleate
    DORYX 80 mgGeneric Name = doxycycline hyclate
    DORYX DRGeneric Name = doxycycline hyclate
    DORYX MPCGeneric Name = doxycycline hyclate
    DOVATOGeneric Name = dolutegravir-lamivudine
    DOXYCYCLINE HYC 80 mgGeneric Name = doxycycline hyclate
    doxycycline hyclate drGeneric Name = doxycycline hyclate
    DOXYCYCLINE IR-DRGeneric Name = doxycycline
    1–10 of 63
    1/7
    No billing or procedure codes in this fragmentmixed
    YARGESAGeneric Name = miglustat
    YCANTHGeneric Name = cantharidin
    YESCARTAGeneric Name = axicabtagene ciloleucel
    YESINTEKGeneric Name = ustekinumab
    YEZTUGOGeneric Name = lenacapavir
    YIMMUGOGeneric Name = immune globulin-intravenous
    YORVIPATHGeneric Name = palopegteriparatide
    YUFLYMAGeneric Name = adalimumab-aaty
    YUPELRIGeneric Name = revefenacin
    YUSIMRYGeneric Name = adalimumab-aqvh
    1–10 of 56
    1/6
    inv-08: Opioid quantity threshold — quantities >90 per month may require prior authorization
    ThresholdQuantities greater than 90 per month may require prior authorization (applies to OXYCODONE ER / OXYCONTIN).
    Applies toOXYCODONE ER; OXYCONTIN (oxycodone hcl extended release).
    Source noteSee policy footnote: †Quantities greater than 90 per month may require prior authorization.
    inv-09: Quantity threshold — quantities greater than 90 per month may require prior authorization
    ThresholdQuantities greater than 90 per month may require prior authorization.
    ScopeApplies to certain products noted with the † footnote in the formulary listing.
    RevisionRevised R02/26 (footnote appears alongside updated entries).
    inv-10: Unlabeled coding key_value placeholder (no label in inventory)
    Threshold (unspecified)Document contains additional entries and classifications; no explicit numeric threshold shown in this fragment.
    ContextSome listings in this fragment reference sodium oxybates and other products without a visible >90/mo footnote in these chunks.
    ActionRefer to full formulary entry or adjacent pages for product-specific quantity limits and footnotes.

    What Providers Must Do

    Prior Authorization

    Prior Authorization Required

    As part of our drug utilization management program, certain prescription drugs require prior authorization before coverage will be approved. Prior authorization requests are processed by our pharmacy benefit manager, Express Scripts, Inc. (ESI). Physicians or authorized providers must call ESI at 1-800-842-2015 to obtain prior authorization prior to dispensing or billing the member's pharmacy benefit. Failure to obtain required prior authorization may result in denial of coverage or benefit under the member's plan.

    • Prior authorization requests must identify the drug name, strength, and quantity requested.
    • Include supporting clinical documentation as applicable (diagnosis, prior therapies tried, lab results, weight/age for pediatric dosing when relevant).
    • For certain opioid extended‑release (ER) products, quantities greater than 90 per month may require prior authorization.
    • Generic versions are not always included in the Prior Authorization Program; verify product-level requirements.
    • The Schedule of Benefits and group-specific plan documents may further define prior authorization and coverage applicability.
    Documentation Required

    Documentation for Prior Authorization Requests

    Providers must submit sufficient documentation to support the medical necessity of the requested drug. At minimum, include the drug name (brand and generic if applicable), dosing regimen, diagnosis or indication, previous therapies and responses, pertinent laboratory or diagnostic results, and any weight/age information necessary for dosing. For specialty or high‑cost agents, attach detailed clinical notes, treatment history, and any genetic or biomarker test results when relevant.

    • Drug name (brand and generic)
    • Diagnosis / ICD-10 code(s)
    • Prior therapies and dates tried with response or rationale for discontinuation
    • Relevant labs, imaging, or biomarker results
    • Prescribed dose, frequency, route, and duration
    • For pediatric patients: age and weight
    Documentation Required

    Documentation Note — Quantity Thresholds

    Quantity‑based requirements and exceptions: some medications (for example select opioid ER products) include quantity thresholds (e.g., >90 per month) that trigger additional review and may require prior authorization; submit justification if request exceeds listed thresholds.

    • If requesting quantities above published thresholds, include clinical rationale and risk mitigation plan.
    • Failure to provide supporting documentation for high‑quantity requests may result in denial.
    Note

    How to Request Authorization

    This document lists drugs that require prior authorization. Providers must submit prior authorization requests for any medication appearing on the list before dispensing when billed under the pharmacy benefit. The inclusion of a medication on this list does not guarantee coverage — verify member benefits and the Schedule of Benefits for plan‑specific limitations.

    • Prior authorization applies regardless of site of care when the drug is billed to the pharmacy benefit.
    • Some drugs on the list are specialty or high‑cost agents and may have additional submission requirements.

    Policy Background

    This drug list is maintained as part of the payer's drug utilization management program and may be updated periodically when new products require prior authorization. Inclusion on the list reflects an administrative prior authorization requirement rather than a clinical coverage determination; providers should contact the pharmacy benefit manager to confirm current requirements.

    Key Definitions

    inv-36: Prior authorization definition — requirement that prescriber request approval from the pharmacy benefit manager before coverage.
    DefinitionPrior authorization: a requirement that a prescriber request approval from the pharmacy benefit manager before a drug will be covered under the member's prescription benefit.
    Responsible entityPrior authorization requests are processed by the pharmacy benefit manager, Express Scripts, Inc. (ESI).
    How to requestPhysicians must call ESI to obtain an authorization (1-800-842-2015).
    inv-37: Drug Classification — therapeutic category assigned to each listed product (e.g., Monoclonal Antibody, Opioid, Test Strip).
    DefinitionDrug Classification = therapeutic category assigned to each listed product (examples shown include Monoclonal Antibody; Analgesics - Opioid; Blood Glucose Test Strip).
    Examples in listEntries in the document pair each drug name with a Drug Classification (e.g., DOJOLVI = Nutrient - Lipids; OXYCODONE ER = Analgesics - Opioid; TEST STRIP = Blood Glucose Test Strip).
    UseClassifications identify the therapeutic area for prior authorization processing and documentation.
    inv-38: Drug Classification — indicates therapeutic category or clinical area (chunk 90).
    DefinitionDrug Classification indicates the therapeutic category or clinical area (examples in fragment: Oncology, Monoclonal Antibody, Antiviral, Gaucher Disease).
    ExamplesYESCARTA = Oncology; YESINTEK/YUFLYMA/YUSIMRY = Monoclonal Antibody; YEZTUGO = Antiviral; YARGESA = Gaucher Disease.
    PurposeUsed to group drugs for prior authorization requirements and coverage review.

    Quantity Limit Notes

    inv-39: OXYCODONE ER / OXYCONTIN — quantity limit >90 per month.
    DrugOXYCODONE ER / OXYCONTIN (oxycodone hcl extended release)
    Quantity limit>90 per month may require prior authorization
    Drug classAnalgesics - Opioid
    inv-40: Unspecified quantity limit note — applies to some products; quantities greater than 90 (chunk 83).
    Note†Quantities greater than 90 per month may require prior authorization.
    Applies toCertain products in the formulary listing that are marked with the † footnote.
    RevisionRevised R02/26 (footnote appears adjacent to updated list entries).
    Policy Summary
    Payerblue cross blue shield - louisiana
    PolicyPrescription Drugs Requiring Prior Authorization
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Last ReviewFeb 26, 2023
    Next Review DateN/A
    Key ActionPhysicians must call Express Scripts, Inc. (ESI) at 1-800-842-2015 to obtain prior authorization.
    SourceLink
    On This Page
    Drugs Requiring Prior AuthorizationListed Drugs and Coding NotesWhat Providers Must DoPolicy BackgroundKey DefinitionsQuantity Limit Notes

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.